Z9F-20767-25349 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-12
Dose 1 — Pfizer-BioNTech
2021-04-02
Dose 2 — Pfizer-BioNTech
2021-04-10
Registered in v-safe
2021-04-10
Survey response — day 7, dose 2
MedDRA: Coagulopathy, Heavy menstrual bleeding — Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Excessive Menstrual flooding & clotting

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-10
Report sent to call center — day 7, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-16
Health check-in — day 14, dose 2
Feeling: Fair

Adult check-in
2021-04-23
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-02
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-07
Survey response — day 35, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: HEAVY HEAVY incapacitating menstrual period.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-07
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-14
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-02
Survey response — 3 months, dose 2
MedDRA: Heavy menstrual bleeding, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: 4 day head coldContinued excessive menstrual bleeding

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-02
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-12
Call 1 — Left Voicemail
2021-10-02
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-04-04
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: I had the omicron variant in January 2022

MedDRA releases: 2024-11 · check-in free text available
2022-04-04
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-04-05
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-12	Pfizer-BioNTech
2	2021-04-02	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-10	Unsuccessful
2021-05-07	Unsuccessful
2021-07-02	Unsuccessful
2022-04-04	Unsuccessful

Free text

Release 7 — day 7, dose 2

2021-04-10

Systemic reaction (other): Excessive Menstrual flooding & clotting

Release 8 — day 35, dose 2

2021-05-07

Symptoms: HEAVY HEAVY incapacitating menstrual period.

Release 9 — 3 months, dose 2

2021-07-02

Symptoms: 4 day head coldContinued excessive menstrual bleeding

Release 11 — 12 months, dose 2

2022-04-04

Symptoms: I had the omicron variant in January 2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Heavy menstrual bleeding	✓	✓	✓
SD	Nasopharyngitis	✓	✓	✓
SRO	Coagulopathy	✓	✓	✓
SRO	Heavy menstrual bleeding	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release